More precisely, when IL-17 is exogenously produced in the microenvironment, tumor growth is enhanced as documented in studies with IL-17−/− mice [43, 44, 70] or intra-tumoral injection of IL-17 siRNA [71]. Here, IL17A is linked to neoplasm.